|
A phase 2 proof of concept study of MBX-8025 in patients with Primary Biliary Cholangitis (PBC) who are inadequate responders to ursodeoxycholic acid (UDCA) |
|
Clinical Study Start-up Time Lines for Rare Orphan Diseases: Can We Do Better? The Example of Primary Biliary Cholangitis |
|
A Pilot study of MBX-8025 in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) |
|
MBX-8025 Phase 2 Study in Primary Biliary Cholangitis (PBC) |
|
MBX-8025 Pilot Study in HoFH Top Line Data |
